Mahmood, Niaz
Arakelian, Ani
Khan, Haseeb Ahmed
Tanvir, Imrana
Mazar, Andrew P.
Rabbani, Shafaat A.
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-156225, PJT-156225)
Article History
Received: 5 July 2019
Revised: 16 January 2020
Accepted: 22 February 2020
First Online: 17 April 2020
Competing interests
: APM is a co-founder, employee, and equity holder in Monopar Therapeutics.